UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: September 22, 2022 4:30 P.M.
Form: F-1
CIK: 0001729214
Company Name: XORTX Therapeutics Inc.
File Number: 333-267328